Tag: Faricimab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Faricimab

Roche's Vabysmo improved vision in underrepresented populations with diabetic macular ...

Added to Collection on: 2024-10-18 22:20:35

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Blindness
Diabetic retinopathy
Macular edema
Ranibizumab
Faricimab
National Eye Institute
Macular degeneration
Intravitreal administration
Anti-VEGF
Conbercept
United States
Roche Group

Click the tags to see associated articles and topics

View Article Details
Roche's Vabysmo improved vision in underrepresented - GlobeNewswire

Added to Collection on: 2024-10-18 21:02:27

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Blindness
Diabetic retinopathy
Macular edema
Ranibizumab
Faricimab
National Eye Institute
Macular degeneration
Intravitreal administration
Anti-VEGF
Conbercept
United States
Roche Group

Click the tags to see associated articles and topics

View Article Details
FDA Approves Ranibizumab Injection for Diabetic Macular Edema - Drug Topics

Added to Collection on: 2025-02-05 00:52:09

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Macular edema
Ranibizumab
Diabetic retinopathy
Intravitreal administration
Anti-VEGF
Faricimab

Click the tags to see associated articles and topics

View Article Details
FDA approves Roche's Susvimo as the first and only - GlobeNewswire

Added to Collection on: 2025-02-04 16:59:57

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Macular edema
Ranibizumab
Eye diseases
Intravitreal administration
Diabetic retinopathy
Faricimab
Macular degeneration
Intravitreal injection
Central retinal vein occlusion
Retina
Roche Group
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
AI-assisted biomarker segmentation offers precision in nAMD disease monitoring

Added to Collection on: 2025-04-19 10:14:56

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Anti-VEGF
Macular degeneration
Ranibizumab
Aflibercept
Vascular endothelial growth factor
Faricimab
Retina
Intravitreal administration
Conbercept
Intravitreal gene therapy

Click the tags to see associated articles and topics

View Article Details
Phase 2 data on IBI302 announced by Innovent Biologics - Ophthalmology Times

Added to Collection on: 2025-05-07 19:45:50

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Anti-VEGF
Dose
Macular degeneration
Brolucizumab
Faricimab
innovent biologics
Innovent
Xiaodong Sun

Click the tags to see associated articles and topics

View Article Details
Innovent Biologics completes first patient dosing in its phase 2 clinical trial assessing ...

Added to Collection on: 2025-05-08 16:05:55

Tags for this article:

Angiogenesis inhibitors
Blindness
Diabetic retinopathy
Anti-VEGF
Faricimab
Macular edema
Vascular endothelial growth factor
Macular degeneration
Intravitreal administration
Bispecific monoclonal antibody
Conbercept
Aflibercept
innovent biologics
Innovent

Click the tags to see associated articles and topics

View Article Details
NEW DAY trial of ILUVIEN for DME does not meet primary endpoint, post-hoc analysis ...

Added to Collection on: 2025-07-27 14:44:48

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Monoclonal antibodies
Macular edema
Diabetic retinopathy
Anti-VEGF
Intravitreal administration
Clinical endpoint
Faricimab
Fluocinolone acetonide
ANI Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
VABYSMO® (faricimab injection) Now Publicly Funded For Macular Edema Secondary to ...

Added to Collection on: 2025-08-15 19:02:23

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Blindness
Faricimab
Macular edema
Diabetic retinopathy
Aflibercept
Central retinal vein occlusion
Branch retinal vein occlusion
Macular degeneration
Retina
Retinopathy
HOFFMANN-LA ROCHE LIMITED
Roche Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
VABYSMO® (faricimab injection) Now Publicly Funded for Macular Edema Secondary to ...

Added to Collection on: 2025-09-29 14:46:28

Tags for this article:

Angiogenesis inhibitors
Retinopathy
Monoclonal antibodies
Blindness
Faricimab
Macular edema
Aflibercept
Diabetic retinopathy
Central retinal vein occlusion
Branch retinal vein occlusion
Macular degeneration
Retina
HOFFMANN-LA ROCHE LIMITED
Roche Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Book a Demo